MHC class II-expressing melanoma cells and breast cancer cells are capable of MHC class II-restricted processing of protein antigens and presentation of peptide epitopes to CD4 T cells [51,57,58,59,60,61,62]. This evidence concerns the gene CD4 and breast carcinoma.